ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,255, issued on Dec. 2, was assigned to Tosk Inc. (Mountain View, Calif.).
"Modulators of RAS GTPase" was invented by Annie L. Lennek (Mountain View, Calif.), Stephen D. Yanofsky (Mountain View, Calif.), Brian D. Frenzel (Mountain View, Calif.), Solomon B. Ungashe (Mountain View, Calif.), William A. Garland (Mountain View, Calif.) and Philip Liaw (Mountain View, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "RAS modulating compounds and methods of using the same are provided. The compounds find use in modulating the activity of a target RAS in a sample. The target RAS can be a mutant RAS that is implicated in a disease of interest. In some case...